C
Market Data
$1.80+$0.69 (+62.16%)
CNTX · Last trade
Prev Close
$1.11
Range (31d)
$1.11 – $1.80
Recent Filings
- 8-K5.5 MBContext Therapeutics Inc.Jan 8, 7:43 AM ET·0001628280-26-001275
- 8-K6.8 MBContext Therapeutics Inc.Nov 5, 4:21 PM ET·0001628280-25-049604
- 10-Q4.6 MBContext Therapeutics Inc.Nov 5, 4:08 PM ET·0001628280-25-049533
- 8-K230.3 KBContext Therapeutics Inc.Oct 24, 4:02 PM ET·0001628280-25-046258
- 8-K149.0 KBContext Therapeutics Inc.Oct 20, 4:04 PM ET·0001628280-25-045513
- 8-K148.9 KBContext Therapeutics Inc.Sep 2, 7:32 AM ET·0001842952-25-000085
- 10-Q4.3 MBContext Therapeutics Inc.Aug 6, 4:07 PM ET·0001842952-25-000081
- 8-K157.6 KBContext Therapeutics Inc.Jun 12, 5:14 PM ET·0001842952-25-000072
- 8-K5.4 MBContext Therapeutics Inc.Jun 2, 7:34 AM ET·0001842952-25-000051
- 10-Q3.7 MBContext Therapeutics Inc.May 7, 4:05 PM ET·0001842952-25-000048
Insiders
10- BERMAN RICHARD JDirector
- Chagin Karen DeborahChief Medical Officer
- Dansky Ullmann ClaudioChief Medical Officer
- Dick Evan G.SVP of R&D
- Kantoff Philip W.Director
- Lehr Martin A.Director, Chief Executive Officer
- Levit Alex C.Chief Legal Officer, Corp. Sec
- Minai-Azary Jennifer LynnChief Financial Officer
- Pasternak AndyDirector
- Rencher William F.Head of CMC and Regulatory
Tickers
Addresses
business
2001 MARKET STREET SUITE 3915 UNIT #15
PHILADELPHIA, PA, 19103
mailing
2001 MARKET STREET SUITE 3915 UNIT #15
PHILADELPHIA, PA, 19103
Former Names
- Context Therapeutics LLC2021-05-03